Diroximel Fumarate and Ilumya Injection
Determining the interaction of Diroximel Fumarate and Ilumya Injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies. MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided. References "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Professional:GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies.
MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided.
- "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Generic Name: diroximel fumarate
Brand name:
Synonyms: n.a.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Ilumya
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diroximel Fumarate-Iluvien
- Diroximel Fumarate-Iluvien Implant
- Diroximel Fumarate-Imatinib
- Diroximel Fumarate-Imatinib Mesylate
- Diroximel Fumarate-Imbruvica
- Diroximel Fumarate-Imbruvica (Ibrutinib Capsules)
- Ilumya Injection-Disalcid
- Ilumya Injection-Diskets
- Ilumya Injection-Diskets Dispersible
- Ilumya Injection-Disney Cars Gummies
- Ilumya Injection-Disney Princess Gummies
- Ilumya Injection-Disopyramide